Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclooxygenase inhibitor therapy in patients with oesophageal adenocarcinoma: pilot study
2005-000988-26Phase 4Terminated
- Sponsor
- Portsmouth Hospitals University NHS Trust
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of meloxicam in esophageal adenocarcinoma (EAC), sponsored by Portsmouth Hospitals University NHS Trust. Primary endpoint: Effect of meloxicam on tumour proliferation markers. Started Feb 2007; status: terminated.
02
Drugs
meloxicam
03
Conditions
esophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on 2005-000988-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000988-26.